EDARBI Trademark

Trademark Overview

On Wednesday, October 21, 2009, a trademark application was filed for EDARBI with the United States Patent and Trademark Office. The USPTO has given the EDARBI trademark a serial number of 79075482. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, June 8, 2020. This trademark is owned by Takeda Pharmaceutical Company Limited. The EDARBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases [, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders ]
edarbi

General Information

Serial Number79075482
Word MarkEDARBI
Filing DateWednesday, October 21, 2009
Status706 - SECTION 71 ACCEPTED
Status DateMonday, June 8, 2020
Registration Number3807333
Registration DateTuesday, June 22, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases [, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOsaka-shi, Osaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJP

Trademark Events

Event DateEvent Description
Wednesday, June 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 23, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, June 23, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 13, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, February 11, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 11, 2021INVALIDATION PROCESSED
Monday, February 8, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, February 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 4, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, February 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 8, 2020NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, June 8, 2020REGISTERED-SEC.71 ACCEPTED
Monday, June 8, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 1, 2020TEAS SECTION 71 RECEIVED
Thursday, November 7, 2019INTERNATIONAL REGISTRATION RENEWED
Thursday, October 3, 2019NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 22, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, March 14, 2016NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, March 14, 2016REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, February 26, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 1, 2016TEAS SECTION 71 & 15 RECEIVED
Tuesday, June 22, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 17, 2010NOTICE OF PUBLICATION
Monday, March 1, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 26, 2010ASSIGNED TO LIE
Tuesday, February 2, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 26, 2010ASSIGNED TO EXAMINER
Tuesday, December 22, 2009APPLICATION FILING RECEIPT MAILED
Wednesday, December 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 7, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Friday, December 4, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

edarbi disorders diseases nervous respiratory allergies osteoporosis gastrointestinal pain neurological bacterial